VLC
Van Leeuwen & Company Portfolio holdings
AUM
$197M
This Quarter Return
+8.61%
1 Year Return
+44.9%
3 Year Return
+76.31%
5 Year Return
+201.32%
10 Year Return
–
AUM
$149M
AUM Growth
+$149M
(+3%)
Cap. Flow
-$2.23M
Cap. Flow
% of AUM
-1.49%
Top 10 Holdings %
Top 10 Hldgs %
43.21%
Holding
84
New
18
Increased
29
Reduced
22
Closed
12
Top Buys
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
$3.47M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
$3.45M |
| 3 |
AbbVie
ABBV
|
$3.05M |
| 4 |
Thermo Fisher Scientific
TMO
|
$2.71M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$2.03M |
Top Sells
| 1 |
Invesco S&P 500 Equal Weight ETF
RSP
|
$10.5M |
| 2 |
Vanguard Growth ETF
VUG
|
$5.91M |
| 3 |
Pfizer
PFE
|
$5.04M |
| 4 |
Elevance Health
ELV
|
$3.65M |
| 5 |
Marsh & McLennan
MMC
|
$1.37M |
Sector Composition
| 1 | Healthcare | 15.48% |
| 2 | Technology | 15.03% |
| 3 | Consumer Discretionary | 12.35% |
| 4 | Financials | 11.81% |
| 5 | Communication Services | 10.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Danaher
DHR
$147B
| – | – |
-2,501
| Closed | -$664K |
|
|
77
Elevance Health
ELV
$71.8B
| – | – |
-7,122
| Closed | -$3.65M |
|
|
78
Marsh & McLennan
MMC
$101B
| – | – |
-8,256
| Closed | -$1.37M |
|
|
79
Pfizer
PFE
$142B
| – | – |
-98,346
| Closed | -$5.04M |
|
80
Invesco QQQ Trust
QQQ
$361B
| – | – |
-2,355
| Closed | -$627K |
|
81
Invesco NASDAQ 100 ETF
QQQM
$58.3B
| – | – |
-5,135
| Closed | -$562K |
|
|
82
Invesco S&P 500 Equal Weight ETF
RSP
$73.6B
| – | – |
-74,252
| Closed | -$10.5M |
|
|
83
Vanguard Growth ETF
VUG
$183B
| – | – |
-27,718
| Closed | -$5.91M |
|
84
The Communication Services Select Sector SPDR Fund
XLC
$25B
| – | – |
-4,192
| Closed | -$201K |
|